{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:13:51Z","timestamp":1788984831483,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01848-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:12:53Z","timestamp":1784873573000},"page":"4519-4537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9165-6026","authenticated-orcid":false,"given":"Leonardo Spagnol","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8484-6251","authenticated-orcid":false,"given":"Ashley S.","family":"Cha-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-9123","authenticated-orcid":false,"given":"Camila Natal","family":"De Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7052-7735","authenticated-orcid":false,"given":"Daniela V.","family":"Pachito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3473-151X","authenticated-orcid":false,"given":"Emily","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2030-0484","authenticated-orcid":false,"given":"Alexa","family":"Russnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-8111","authenticated-orcid":false,"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-7175","authenticated-orcid":false,"given":"Isabella","family":"Doche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"2","key":"1848_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","volume":"14","author":"N Islam","year":"2015","unstructured":"Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81\u20139.","journal-title":"Autoimmun Rev"},{"key":"1848_CR2","doi-asserted-by":"crossref","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;16;3:17011.","DOI":"10.1038\/nrdp.2017.11"},{"issue":"3","key":"1848_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"HH Lee","year":"2020","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(3):675\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"1848_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CCID.S245649","volume":"13","author":"M Benigno","year":"2020","unstructured":"Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, et al. A large cross-sectional survey study of the prevalence of alopecia areata in the United States. Clin Cosmet Investig Dermatol. 2020;13:259\u201366.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"11","key":"1848_CR5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/jdv.14959","volume":"32","author":"MA Richard","year":"2018","unstructured":"Richard MA, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the \u00ab\u202fOBJECTIFS PEAU\u202f\u00bb study. J Eur Acad Dermatol Venereol. 2018;32(11):1967\u201371.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1848_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/bjd.20628","volume":"186","author":"M Harries","year":"2022","unstructured":"Harries M, Macbeth AE, Holmes S, Chiu WS, Gallardo WR, Nijher M, et al. The epidemiology of alopecia areata: a population-based cohort study in UK primary care. Br J Dermatol. 2022;186(2):257\u201365.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1848_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13555-021-00512-0","volume":"11","author":"A Mostaghimi","year":"2021","unstructured":"Mostaghimi A, Napatalung L, Sikirica V, Winnette R, Xenakis J, Zwillich SH, et al. Patient perspectives of the social, emotional and functional impact of alopecia areata: a systematic literature review. Dermatol Ther (Heidelb). 2021;11(3):867\u201383.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"10","key":"1848_CR8","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.jid.2022.02.019","volume":"142","author":"M Senna","year":"2022","unstructured":"Senna M, Ko J, Glashofer M, Edison-Heredia E, Zhu B, Shapiro J. Predictors of QOL in patients with alopecia areata. J Investig Dermatol. 2022;142(10):2646\u201350.","journal-title":"J Investig Dermatol"},{"key":"1848_CR9","doi-asserted-by":"crossref","unstructured":"Lauron S, Plasse C, Vaysset M, Pereira B, D\u2019Incan M, Rondepierre F, et al. Prevalence and odds of depressive and anxiety disorders and symptoms in children and adults with alopecia areata: a systematic review and meta-analysis. JAMA Dermatol. 2023;159(3):281\u20138","DOI":"10.1001\/jamadermatol.2022.6085"},{"issue":"1","key":"1848_CR10","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","volume":"20","author":"N Mesinkovska","year":"2020","unstructured":"Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of illness in alopecia areata: a cross-sectional online survey study. J Investig Dermatol Symp Proc. 2020;20(1):S62\u20138.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"1848_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1590\/abd1806-4841.20188802","volume":"93","author":"HA Miot","year":"2018","unstructured":"Miot HA, Penna GDO, Ramos AMC, Penna MLF, Schmidt SM, Luz FB, et al. Profile of dermatological consultations in Brazil (2018). An Bras Dermatol. 2018;93(6):916\u201328.","journal-title":"An Bras Dermatol"},{"issue":"2","key":"1848_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jped.2020.02.002","volume":"97","author":"IZ Miotto","year":"2021","unstructured":"Miotto IZ, Bessa VR, Vasconcelos LBDA, Samorano LP, Rivitti-Machado MC, Oliveira ZNPD. Pediatric dermatoses pattern at a Brazilian reference center. J Pediatr. 2021;97(2):211\u20138.","journal-title":"J Pediatr"},{"issue":"1","key":"1848_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13555-022-00845-4","volume":"13","author":"MM Vel\u00e1squez-Lopera","year":"2023","unstructured":"Vel\u00e1squez-Lopera MM, Hern\u00e1ndez N, Jansen AM, Garc\u00eda AL, Luna PC, Rico-Restrepo M, et al. Alopecia areata in Latin America: where are we and where are we going? Dermatol Ther (Heidelb). 2023;13(1):95\u2013114.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1848_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874677","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Pan L, Wu Y. Epidemiological trends in Alopecia areata at the global, regional, and national levels. Front Immunol. 2022;13:874677.","journal-title":"Front Immunol"},{"issue":"2","key":"1848_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.abd.2024.10.001","volume":"100","author":"PM Ramos","year":"2025","unstructured":"Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, et al. II consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata. An Bras Dermatol. 2025;100(2):328\u201341.","journal-title":"An Bras Dermatol"},{"issue":"11","key":"1848_CR16","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1848_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8):e010352.","journal-title":"BMJ Open"},{"key":"1848_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","volume":"9","author":"V Higgins","year":"2000","unstructured":"Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2000;9:371\u201380.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"1848_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, Doslikova K, Davis VA, Karavali M, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"key":"1848_CR20","unstructured":"European Pharmaceutical Marketing Research Association (EphMRA) Code of Conduct [Internet]. [cited 2025]. https:\/\/www.ephmra.org\/code-conduct-aer. (2025)"},{"key":"1848_CR21","unstructured":"Health Information Technology Act [Internet] [cited 2025]. https:\/\/www.healthit.gov\/sites\/default\/files\/hitech_act_excerpt_from_arra_with_index.pdf. (2009)"},{"key":"1848_CR22","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1007\/s13555-024-01280-3","volume":"14","author":"P Anderson","year":"2024","unstructured":"Anderson P, Piercy J, Austin J, Marwaha S, Hanson KA, Law EH, et al. Alopecia areata treatment patterns and satisfaction: results of a real-world cross-sectional survey in Europe. Dermatol Ther (Heidelb). 2024;14(12):3243\u201358.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1848_CR23","unstructured":"Al Ajlan M, Alenzi K, Alhaddab M, AlHarbi I, Almoar M, Alturaiki A, et al. Clinical characteristics, treatment patterns, and quality of life impacts among patients with Alopecia Areata in Saudi Arabia and the United Arab Emirates. European Academy of Dermatology and Venereology; September 17\u201321, 2025; Paris, France."},{"issue":"2","key":"1848_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/bjd\/ljae385","volume":"192","author":"MJ Harries","year":"2024","unstructured":"Harries MJ, Ascott A, Asfour L, Farrant P, Hale G, Holmes S, et al. British Association of Dermatologists living guideline for managing people with alopecia areata 2024. Br J Dermatol. 2024;192(2):190\u2013205.","journal-title":"Br J Dermatol"},{"key":"1848_CR25","doi-asserted-by":"publisher","first-page":"adv12445","DOI":"10.2340\/actadv.v103.12445","volume":"103","author":"N Done","year":"2023","unstructured":"Done N, Bartolome L, Swallow E, Gao W, Carley C, Wang T, et al. Real-world treatment patterns among patients with alopecia areata in the USA: a retrospective claims analysis. Acta Derm Venereol. 2023;103:adv12445.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1848_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/1346-8138.16615","volume":"50","author":"E Campos-Alberto","year":"2023","unstructured":"Campos-Alberto E, Hirose T, Napatalung L, Ohyama M. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: a descriptive study using Japan medical data center claims database. J Dermatol. 2023;50(1):37\u201345.","journal-title":"J Dermatol"},{"key":"1848_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.abd.2020.05.006","volume":"95","author":"PM Ramos","year":"2020","unstructured":"Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, et al. Consensus on the treatment of alopecia areata \u2013 Brazilian Society of Dermatology. An Bras Dermatol. 2020;95:39\u201352.","journal-title":"An Bras Dermatol"},{"issue":"8","key":"1848_CR28","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s13555-023-00963-7","volume":"13","author":"A Ammoury","year":"2023","unstructured":"Ammoury A, Hegazy R, Al Talhab S, Ameen A, Hassan N, Ghoubar M. Treatment patterns and unmet needs in the management of alopecia areata: results of a physician\u2019s survey in the Middle East. Dermatol Ther. 2023;13(8):1801\u201315.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1848_CR29","doi-asserted-by":"publisher","first-page":"AB43","DOI":"10.1016\/j.jaad.2024.07.180","volume":"91","author":"A Nohria","year":"2024","unstructured":"Nohria A, Klein E, Taiw\u00f2 D, Kakpovbia E, Laughter M, Lo Sicco K. 52723 exploring disparities in access to JAK-STAT inhibitors among patients with alopecia areata: a retrospective analysis. J Am Acad Dermatol. 2024;91(3):AB43.","journal-title":"J Am Acad Dermatol"},{"key":"1848_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100426","volume":"19","author":"M Coube","year":"2023","unstructured":"Coube M, Nikoloski Z, Mrejen M, Mossialos E. Inequalities in unmet need for health care services and medications in Brazil: a decomposition analysis. The Lancet Regional Health\u2014Americas. 2023;19:100426.","journal-title":"The Lancet Regional Health\u2014Americas"},{"issue":"4","key":"1848_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/bjd\/ljac128","volume":"188","author":"J-T Maul","year":"2023","unstructured":"Maul J-T, Fr\u00f6hlich F, Maul LV, Stunnenberg R, Valenzuela F, De La Cruz C, et al. Access to psoriasis treatment in Brazil and Chile: a cross-sectional multicentre Global Healthcare Study on Psoriasis. Br J Dermatol. 2023;188(4):533\u201341.","journal-title":"Br J Dermatol"},{"key":"1848_CR32","unstructured":"Alnaeem A, Al Safi MM, Ameen A, Mohamed PA, AlAjlan MAF, Alanazi K, et al., editors. Dermatologist Perceptions and Experiences Treating Alopecia Areata in Saudi Arabia and the United Arab Emirates. European Academy of Dermatology & Veneraology Congress; September 17\u201320, 2025; Paris, France."},{"key":"1848_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","volume":"12","author":"B King","year":"2022","unstructured":"King B, Senna MM, Ohyama M, Tosti A, Sinclair RD, Ball S, et al. Defining severity in alopecia areata: current perspectives and a multidimensional framework. Dermatol Ther. 2022;12:825\u201334.","journal-title":"Dermatol Ther"},{"issue":"2","key":"1848_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","volume":"86","author":"BA King","year":"2022","unstructured":"King BA, Mesinkovska NA, Craiglow B, Kindred C, Ko J, McMichael A, et al. Development of the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022;86(2):359\u201364.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1848_CR35","first-page":"59","volume":"20","author":"DA Lintzeri","year":"2022","unstructured":"Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata - current understanding and management. J Dtsch Dermatol Ges. 2022;20(1):59\u201390.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"9","key":"1848_CR36","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","volume":"38","author":"M Senna","year":"2021","unstructured":"Senna M, Ko J, Tosti A, Edson-Heredia E, Fenske DC, Ellinwood AK, et al. Alopecia areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims. Adv Ther. 2021;38(9):4646\u201358.","journal-title":"Adv Ther"},{"issue":"10387","key":"1848_CR37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","volume":"401","author":"B King","year":"2023","unstructured":"King B, Zhang X, Harcha WG, Szepietowski JC, Shapiro J, Lynde C, et al. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial. Lancet. 2023;401(10387):1518\u201329.","journal-title":"Lancet"},{"issue":"18","key":"1848_CR38","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","volume":"386","author":"B King","year":"2022","unstructured":"King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, et al. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med. 2022;386(18):1687\u201399.","journal-title":"N Engl J Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01848-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:21:31Z","timestamp":1788981691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1848"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01848-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Leonardo Spagnol Abraham declares participation in clinical trials for Janssen; sponsored lectures for Vichy, GSK, Pfizer Inc., Ach\u00e8, and FQM Melora; event support for Pfizer Inc. and Tricholab; and an advisory board for Pfizer Inc. and Vichy Laboratoires. Ashley S. Cha-Silva and Samantha K Kurosky are employees of Pfizer Inc. and own stock\/stock options in Pfizer Inc. Camila Natal De Gaspari and Daniela V. Pachito are employees of Pfizer Brazil and own stock\/stock options in Pfizer Inc. Peter Anderson, Emily Quinones, and Alexa Russnak are employees of Adelphi Real World, Bollington, UK. Isabella Doche declares participation in advisory boards for Veradermics and Pfizer Inc.; consultant honoraria from Veradermics, Ach\u00e8, Pfizer Inc. and Loreal; speaker honoraria from Pierre-Fabre, Loreal, GSK and Loreal.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A complete description of the survey methods has been previously published and validated [\n                      \n                      \u2013\n                      \n                      ]. Using a checkbox, patients provided informed consent for use of their anonymized and aggregated data for research and publication in scientific journals. Data were collected in such a way that patients and physicians could not be identified directly; all data were aggregated and de-identified before receipt. Data collection was undertaken in line with European Pharmaceutical Marketing Research Association [\n                      \n                      ] guidelines, and as such it does not require ethics committee approval. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the Health Information Technology for Economic and Clinical Health Act legislation [\n                      \n                      ].","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}